Hengkang Pharmaceutical

Haoyue Health, formerly known as Hengkang Medical Group, is a diversified Chinese healthcare enterprise specializing in pharmaceutical manufacturing and hospital management services. The company's pharmaceutical division, centered around subsidiaries such as Sichuan Hengkang Pharmaceutical, is recognized for its Traditional Chinese Medicine (TCM) products, notably the Duyihe capsule for pain relief and hemostasis. In addition to TCM, the company produces a range of chemical generic drugs and operates multiple comprehensive and specialized hospitals across China, focusing on oncology, maternity, and cardiovascular care. Following a significant bankruptcy restructuring in 2022, the company rebranded as Haoyue Health to emphasize its modernized focus on integrated health technology and medical service optimization.